Dupilumab in type 2 airway inflammation-a step forward in targeted therapy for COPD. Tan RVS, Aung HWW, Flynn C, Greening NJ, et al. J Allergy Clin Immunol 2024;153:404-406.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tan RVS, Aung HWW, Flynn C, Greening NJ, et al. Dupilumab in type 2 airway inflammation-a step forward in targeted therapy for COPD. J Allergy Clin Immunol 2024;153:404-406.
PMID: 37944566